← Eichor
Study identifier: NCT07694063 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Online Hatha Yoga Program as an Add-On Therapy for Episodic High-Frequency Migraine

Condition: Migraine  ·  Sponsor: University of Seville

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

This randomized controlled trial aims to evaluate the effectiveness and feasibility of an online Hatha yoga program as an adjunct (add-on) therapy for patients with high-frequency episodic migraine. Participants will be randomly assigned to either an intervention group receiving a 12-week home-based online Hatha yoga program in addition to usual pharmacological treatment, or a control group receiving usual pharmacological care only. Outcomes include migraine frequency, pain intensity, functional disability, sleep quality, psychological symptoms, and adherence.

This description comes directly from the study's public registry record.

Talk to the study team

Cristina García Muñoz, PhD, PT  ·  +34954551468  ·  ccriss.g@gmail.com

Sahar TaghipourAzam, PT  ·  +34654238544  ·  saharttpp@gmail.com; yogamigincidencias@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital Virgen del RocioSeville, Sevilla, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07694063